Clinical Study Data Request Registered Users, Please Login

Scroll down the list of studies provided below. Studies are listed by study medicine in alphabetical order. Alternatively you can browse the list of studies using the search function.

To select studies and submit a research proposal or enquiry, go back to the Home page and select View and submit.

This takes you back to the previous page to enable you to view studies from a different sponsor.

Select medicine, medical condition or phase from the drop down boxes. This searches all the available clinical studies. Selecting from more than one drop down box will “and” the criteria.

Find by:


Alternatively search for studies using the Eisai Clinical Study Identification Number or study title by entering text and clicking search.

 

7 found

Click the study title to find more information about the study.

EISAI-E2007-G000-332
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Medicine: Fycompa, Condition: Primary Generalised Tonic Clonic Seizures, Phase: 3, Clinical Study ID: E2007-G000-332, Sponsor: Eisai
EISAI-E2007-G000-332EXT
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Medicine: Fycompa, Condition: Primary Generalised Tonic Clonic Seizures, Phase: 3, Clinical Study ID: E2007-G000-332EXT, Sponsor: Eisai
EISAI-E7080-G000-201
Phase II, Multicenter, Open-label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology

Medicine: Lenvatinib, Condition: Differentiated Thyroid Cancer, Phase: 2, Clinical Study ID: E7080-G000-201, Sponsor: Eisai
EISAI-E7080-J081-208
A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer

Medicine: Lenvatinib, Condition: Thyroid Cancer, Phase: 2, Clinical Study ID: E7080-J081-208, Sponsor: Eisai
EISAI-E7080-G000-303
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer

Medicine: Lenvatinib, Condition: Differentiated Thyroid Cancer, Phase: 3, Clinical Study ID: E7080-G000-303, Sponsor: Eisai
EISAI-E7080-J081-103
An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Medicine: Lenvatinib, Condition: Solid Tumors, Phase: 1, Clinical Study ID: E7080-J081-103, Sponsor: Eisai
EISAI-E7080-J081-105
A Phase 1 Study of E7080 in Subjects With Solid Tumor

Medicine: Lenvatinib, Condition: Solid Tumors, Phase: 1, Clinical Study ID: E7080-J081-105, Sponsor: Eisai
First Previous 1 Next Last